EW vs. MCK: Edwards Lifesciences vs. McKesson Stock Comparison
How do Edwards Lifesciences (EW) and McKesson (MCK) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Edwards Lifesciences (EW) and McKesson (MCK) both fall under the Health Care Equipment & Services industry group, but EW is classified in Health Care Equipment & Supplies while MCK is classified in Health Care Providers & Services.
| Profile Item | EW | MCK |
|---|---|---|
| Name | Edwards Lifesciences Corporation | McKesson Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Equipment | Health Care Distributors |
| Market Capitalization | 58.73 billion USD | 122.48 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 27, 2000 | November 10, 1994 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | EW | MCK |
|---|---|---|
| Total Return (1Y) | 25.08% | 25.40% |
| Total Return (3Y, Annualized) | 17.28% | 32.67% |
| Total Return (5Y, Annualized) | -2.77% | 37.84% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | EW | MCK |
|---|---|---|
| Volatility (1Y, Annualized) | 25.58% | 31.71% |
| Beta (5Y) | 0.78 | 0.26 |
| Max Drawdown (5Y) | -54.32% | -27.17% |
| Avg. Volume (3M) | 3.69M | 822.69K |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | EW | MCK |
|---|---|---|
| Sharpe Ratio (1Y) | 0.81 | 0.67 |
| Sortino Ratio (1Y) | 1.23 | 1.15 |
Profitability
ROE (TTM)
Capital efficiency shows on one side only: Edwards Lifesciences (EW) earns 9.33% on shareholders’ equity, ranked against its industry; McKesson (MCK) has no ROE this period.
EW
Health Care Equipment & Services industry group
9.33%
- Max
- 47.61%
- Q3
- 14.36%
- EW
- 9.33%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
MCK
Health Care Equipment & Services industry group
--
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
- MCK
- --
Net Margin (TTM)
Edwards Lifesciences (EW) at 15.30% retains a top-quartile share of revenue as profit, ahead of McKesson (MCK) at 1.12%, which keeps about the industry-typical share.
EW
Health Care Equipment & Services industry group
15.30%
- Max
- 29.35%
- EW
- 15.30%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
MCK
Health Care Equipment & Services industry group
1.12%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- MCK
- 1.12%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Edwards Lifesciences (EW) at 30.15% operates in the top operating margin quartile, ahead of McKesson (MCK) at 1.48%, which runs around its industry’s norm.
EW
Health Care Equipment & Services industry group
30.15%
- Max
- 35.43%
- EW
- 30.15%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
MCK
Health Care Equipment & Services industry group
1.48%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- MCK
- 1.48%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | EW | MCK |
|---|---|---|
| ROE (TTM) | 9.33% | -- |
| ROA (TTM) | 8.77% | 4.72% |
| Net Margin (TTM) | 15.30% | 1.12% |
| Operating Margin (TTM) | 30.15% | 1.48% |
| Gross Margin (TTM) | 78.02% | 3.65% |
Growth
Revenue Growth
Both Edwards Lifesciences (EW) at 11.55% and McKesson (MCK) at 12.36% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
McKesson (MCK) at 49.22% sits in the top EPS growth quartile, while Edwards Lifesciences (EW) at -73.74% is in the bottom quartile, showing a clear gap in earnings momentum.
Growth Metrics
| Metric | EW | MCK |
|---|---|---|
| Revenue Growth (YoY) | 11.55% | 12.36% |
| Revenue Growth (3Y CAGR) | 10.77% | 13.39% |
| EPS Growth (YoY) | -73.74% | 49.22% |
| EPS Growth (3Y CAGR) | -9.14% | 15.31% |
Financial Strength
Current Ratio (MRQ)
Edwards Lifesciences (EW) at 4.60 carries current ratio above its industry’s typical mid-range, while McKesson (MCK) at 0.90 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.
EW
Health Care Equipment & Services industry group
4.60
- Max
- 7.59
- EW
- 4.60
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
MCK
Health Care Equipment & Services industry group
0.90
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- MCK
- 0.90
- Min
- 0.30
Debt / Equity (MRQ)
Only one side’s leverage can be read here: Edwards Lifesciences (EW) carries debt-to-equity ratio of 0.06 against its industry range, while McKesson (MCK) reports no figure this period.
EW
Health Care Equipment & Services industry group
0.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- EW
- 0.06
- Min
- 0.00
MCK
Health Care Equipment & Services industry group
--
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
- MCK
- --
Financial Strength Metrics
| Metric | EW | MCK |
|---|---|---|
| Current Ratio (MRQ) | 4.60 | 0.90 |
| Debt / Equity (MRQ) | 0.06 | -- |
| Net Debt / EBITDA | -1.88 | 0.64 |
Dividends
Dividend Yield (TTM)
Edwards Lifesciences (EW) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile McKesson (MCK) reports a yield of 0.32%, ranking against industry peers normally.
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
MCK
Health Care Equipment & Services industry group
0.32%
- MCK
- 0.32%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Edwards Lifesciences (EW) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile McKesson (MCK) reports a payout of 8.77%, ranking against industry peers normally.
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
MCK
Health Care Equipment & Services industry group
8.77%
- MCK
- 8.77%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | EW | MCK |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.32% |
| Dividend Payout Ratio (TTM) | 0.00% | 8.77% |
Valuation
P/E Ratio (TTM)
McKesson (MCK) at 27.36 is near its industry’s usual P/E ratio, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — EW needs stronger growth or earnings quality to justify the premium.
EW
Health Care Equipment & Services industry group
59.38
- Max
- 80.41
- EW
- 59.38
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
MCK
Health Care Equipment & Services industry group
27.36
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- MCK
- 27.36
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
McKesson (MCK) at 0.29 looks cheap on sales in the lower P/S ratio quartile, while Edwards Lifesciences (EW) at 8.80 looks rich in the upper quartile — a clear gap in price per dollar of revenue.
EW
Health Care Equipment & Services industry group
8.80
- EW
- 8.80
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
MCK
Health Care Equipment & Services industry group
0.29
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- MCK
- 0.29
- Min
- 0.03
P/B Ratio (MRQ)
McKesson (MCK) reports a negative P/B ratio of -30.85, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Edwards Lifesciences (EW) reports 5.41, ranking against industry peers normally.
EW
Health Care Equipment & Services industry group
5.41
- Max
- 11.68
- Q3
- 6.12
- EW
- 5.41
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
MCK
Health Care Equipment & Services industry group
-30.85
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
- MCK
- -30.85
Valuation Metrics
| Metric | EW | MCK |
|---|---|---|
| P/E Ratio (TTM) | 59.38 | 27.36 |
| P/S Ratio (TTM) | 8.80 | 0.29 |
| P/B Ratio (MRQ) | 5.41 | -30.85 |
| Free Cash Flow Yield (TTM) | 1.95% | 6.04% |